Innovative Research Award
Yazan Barqawi
Astra Zeneca, United States
| Yazan Barqawi |
| Affiliation |
Astra Zeneca |
| Country |
United States |
| Scopus ID |
56716382800 |
| Documents |
8 |
| Citations |
61 |
| h-index |
4 |
| Subject Area |
Innovation and Technology Strategy |
| Event |
Business Global Awards |
| ORCID |
0000-0002-3045-6813 |
Yazan Barqawi is a researcher affiliated with Astra Zeneca in the United States whose scholarly record encompasses research at the intersection of healthcare, evidence-based intervention, treatment patterns, and innovation-oriented strategy. The available publication record includes peer-reviewed and conference contributions addressing digital health education in heart failure and real-world treatment patterns in hematological malignancies. These outputs provide a basis for considering the researcher within an innovation and technology strategy context, particularly where evidence generation supports the evaluation and adoption of healthcare interventions.
Abstract
This academic recognition profile presents the research record of Yazan Barqawi in relation to the Innovative Research Award. The documented portfolio includes research on digital health interventions incorporating educational components for patients with heart failure, as well as real-world treatment patterns and outcomes in hematological diseases. A systematic review and meta-analysis published in Healthcare in August 2026 examined the clinical impact of digital health interventions with educational components for patients with heart failure. [1] A related preprint addressing digital health education for patients with heart failure was published in December 2025. [2] Additional conference research examined first- and second-line treatment patterns in B-cell acute lymphoblastic leukemia and real-world treatment patterns and outcomes among treatment-naive patients with mantle cell lymphoma. [3] [4]
Keywords
Keywords: Innovative Research Award; digital health; health education; heart failure; systematic review; meta-analysis; clinical impact; real-world evidence; hematology; acute lymphoblastic leukemia; mantle cell lymphoma; treatment patterns; healthcare innovation; technology strategy; evidence-based research.
Introduction
Digital transformation in healthcare has expanded the role of technology-supported interventions in patient education, clinical monitoring, communication, and self-management. Systematic reviews and meta-analyses are particularly important in this environment because they synthesize available evidence and can clarify the extent to which digital interventions are associated with measurable clinical outcomes. The publication on the clinical impact of digital health interventions with educational components for patients with heart failure reflects this evidence-synthesis approach. [1]
The research portfolio also includes studies based on real-world treatment data. Such research is relevant to healthcare strategy because treatment patterns observed in routine practice may complement evidence generated through controlled research settings. The documented work on B-cell acute lymphoblastic leukemia and mantle cell lymphoma illustrates the application of observational and health-data approaches to understanding treatment practices and outcomes. [3] [4]
Research Profile
Yazan Barqawi’s indexed research profile contains 8 documents, 61 citations, and an h-index of 4 according to the supplied researcher information. The portfolio spans journal publication, preprint dissemination, and conference research. Its subject-area framing is Innovation and Technology Strategy, while the documented studies are strongly situated within healthcare research and evidence-based evaluation.
The available record indicates several complementary research characteristics:
- Application of systematic review and meta-analysis methods to evaluate digital health interventions.
- Investigation of educational components within digital health interventions for patients with heart failure.
- Analysis of treatment patterns in hematological malignancies using real-world evidence.
Research Contributions
A principal contribution in the documented portfolio is the systematic evaluation of digital health interventions containing educational components for patients with heart failure. The associated article, published in Healthcare, uses systematic review and meta-analysis methodology to investigate clinical impact. [1] This type of research is relevant to digital healthcare strategy because it consolidates findings from multiple studies rather than relying on a single intervention or clinical setting.
The corresponding preprint, published in December 2025, provides an earlier dissemination of research focused specifically on digital health education for patients with heart failure. [2] The relationship between preprint and subsequent journal publication illustrates a research-development pathway from preliminary dissemination toward formal peer-reviewed publication.
Publications
The supplied publication record includes the following documented outputs:
- Clinical Impact of Digital Health Interventions with Educational Components for Patients with Heart Failure: A Systematic Review and Meta-Analysis.[1]
- Clinical Impact of Digital Health Education for Patients with Heart Failure: A Systematic Review and Meta-Analysis (Preprint).[2]
- FIRST-LINE (1L) AND SECOND-LINE (2L) TREATMENT PATTERNS IN PATIENTS WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN DIFFERENT TIME PERIODS.[3]
- 269 | REAL-WORLD TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH TREATMENT-NAIVE MANTLE CELL LYMPHOMA IN THE UK, SWEDEN, AND FRANCE.
Research Impact
The available bibliometric profile records 61 citations and an h-index of 4 across 8 documents. These indicators provide quantitative information concerning the visibility and citation activity of the indexed record. They should be interpreted alongside publication quality, methodological rigor, disciplinary context, collaboration, and the specific contribution of individual studies.
The subject matter of the documented research has potential relevance to healthcare innovation through two complementary evidence pathways. Digital health research can contribute to understanding the effectiveness and clinical implications of technology-supported education, while real-world treatment research can provide evidence concerning how therapies are used and outcomes observed in routine practice. The systematic review and meta-analysis published in Healthcare is particularly relevant to evidence synthesis in digital health. [1]
The international scope of the hematological oncology research, including data or observations relating to the United Kingdom, Sweden, and France, also demonstrates attention to cross-country real-world treatment patterns. [4] Such comparative perspectives can be useful when examining variation in treatment practices and the transferability of evidence across healthcare environments.
Award Suitability
The documented record provides several areas of alignment with the Innovative Research Award. The strongest alignment is the combination of digital health research, evidence synthesis, patient education, and real-world healthcare analytics. These themes correspond to contemporary approaches in which technological innovation is assessed not only by novelty but also by evidence concerning clinical relevance and practical application.
The award suitability assessment can be summarized through the following dimensions:
- Research contribution: The portfolio contains peer-reviewed and conference research addressing clinically relevant healthcare questions.
- Innovation relevance: Digital health education and technology-supported interventions represent contemporary areas of healthcare innovation.
Conclusion
Yazan Barqawi’s documented research portfolio represents an applied evidence-oriented contribution spanning digital health, patient education, systematic evidence synthesis, and real-world treatment research. The publication record includes a 2026 systematic review and meta-analysis in Healthcare, a related preprint, and conference research addressing treatment patterns in hematological malignancies. [1] [2] [3] [4]
External Links
References
- Healthcare. (2026). Clinical Impact of Digital Health Interventions with Educational Components for Patients with Heart Failure: A Systematic Review and Meta-Analysis. Publication date: 9 August 2026. DOI: 10.3390/healthcare14162460.
https://doi.org/10.3390/healthcare14162460
- JMIR Preprints. (2025). Clinical Impact of Digital Health Education for Patients with Heart Failure: A Systematic Review and Meta-Analysis (Preprint). Publication date: 22 December 2025. DOI: 10.2196/preprints.90163.
https://doi.org/10.2196/preprints.90163
- European Hematology Association. (2025). FIRST-LINE (1L) AND SECOND-LINE (2L) TREATMENT PATTERNS IN PATIENTS WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN DIFFERENT TIME PERIODS. EHA 2025 Congress, published 12 June 2025.
https://library.ehaweb.org/eha/2025/eha2025-congress/4161446/nikesh.shah.first-line.281l29.and.second-line.282l29.treatment.patterns.in.htm
- Wiley. (2025). 269 | REAL-WORLD TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH TREATMENT-NAIVE MANTLE CELL LYMPHOMA IN THE UK, SWEDEN, AND FRANCE. Hematological Oncology, June 2025. DOI: 10.1002/hon.70094_269.
https://doi.org/10.1002/hon.70094_269
- Elsevier. (n.d.). Scopus author details: Yazan Barqawi, Author ID 56716382800. Scopus.
https://www.scopus.com/pages/authors/56716382800
- ORCID. (n.d.). ORCID record for Yazan Barqawi.
https://orcid.org/0000-0002-3045-6813